Onkure Therapeutics, Stock Technical Analysis

OKUR Stock   8.38  0.33  4.10%   
As of the 22nd of December, OnKure Therapeutics, holds the risk adjusted performance of (0.14), and Coefficient Of Variation of (544.05). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of OnKure Therapeutics,, as well as the relationship between them. Please check OnKure Therapeutics, variance and skewness to decide if OnKure Therapeutics, is priced some-what accurately, providing market reflects its current price of 8.38 per share. Given that OnKure Therapeutics, has information ratio of (0.19), we recommend you to check out OnKure Therapeutics,'s recent market performance to make sure the company can sustain itself at a future point.

OnKure Therapeutics, Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as OnKure, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to OnKure
  
OnKure Therapeutics,'s Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
OnKure Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of OnKure Therapeutics, technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of OnKure Therapeutics, trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

OnKure Therapeutics, Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of OnKure Therapeutics, volatility. High ATR values indicate high volatility, and low values indicate low volatility.

OnKure Therapeutics, Trend Analysis

Use this graph to draw trend lines for OnKure Therapeutics,. You can use it to identify possible trend reversals for OnKure Therapeutics, as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual OnKure Therapeutics, price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

OnKure Therapeutics, Best Fit Change Line

The following chart estimates an ordinary least squares regression model for OnKure Therapeutics, applied against its price change over selected period. The best fit line has a slop of   0.14  , which may suggest that OnKure Therapeutics, market price will keep on failing further. It has 122 observation points and a regression sum of squares at 769.06, which is the sum of squared deviations for the predicted OnKure Therapeutics, price change compared to its average price change.

About OnKure Therapeutics, Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of OnKure Therapeutics, on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of OnKure Therapeutics, based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on OnKure Therapeutics, price pattern first instead of the macroeconomic environment surrounding OnKure Therapeutics,. By analyzing OnKure Therapeutics,'s financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of OnKure Therapeutics,'s intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to OnKure Therapeutics, specific price patterns or momentum indicators. Please read more on our technical analysis page.

OnKure Therapeutics, December 22, 2024 Technical Indicators

Most technical analysis of OnKure help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for OnKure from various momentum indicators to cycle indicators. When you analyze OnKure charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Additional Tools for OnKure Stock Analysis

When running OnKure Therapeutics,'s price analysis, check to measure OnKure Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OnKure Therapeutics, is operating at the current time. Most of OnKure Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of OnKure Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OnKure Therapeutics,'s price. Additionally, you may evaluate how the addition of OnKure Therapeutics, to your portfolios can decrease your overall portfolio volatility.